Moshe Alafi Net Worth & Insider Trades
Moshe Alafi Intra-Cellular Therapies, Inc
What is Moshe Alafi's Net Worth?
The current estimated net worth of Intra-Cellular Therapies, Inc's Moshe Alafi is estimated to be about $198.06M . Moshe Alafi owns about 3,953,270 units of Intra-Cellular Therapies, Inc common stock. In the last 3 years at Intra-Cellular Therapies, Inc, Moshe Alafi has sold an estimated value of $100.01K worth.
What is Moshe Alafi's Past Insider Trading?
Moshe Alafi's largest purchase order was 258,065 units , worth over $4M on October 3, 2017. Moshe Alafi's largest sale order was 15,742 units , worth over $100.01K on July 10, 2014. In total, Moshe Alafi has made about 9 transactions over 3 years of their time at Intra-Cellular Therapies, Inc. Moshe Alafi usually trades in November, with the busiest year in 2014.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
MOSHE ALAFI
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |
InsideArbitrage
What is Moshe Alafi's' Mailing Address?
- Mailing address is 1311 Orleans Drive Sunnyvale CA 94089 CA
Intra-Cellular Therapies, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Compensation
|
Total
|
---|---|---|---|---|---|---|---|
Sharon Mates, Ph.D. | 2020 | $766,800 | $690,120 | $2,799,998 | $1,199,994 | $18,767 | $5,475,679 |
Sharon Mates, Ph.D. | 2019 | $744,500 | $759,400 | $1,599,996 | $1,600,003 | $20,661 | $4,724,560 |
Sharon Mates, Ph.D. | 2018 | $722,800 | $585,500 | $1,593,735 | $1,556,410 | $18,024 | $4,476,469 |
Lawrence J. Hineline | 2020 | $463,400 | $222,432 | $1,049,984 | $449,993 | $20,374 | $2,206,183 |
Lawrence J. Hineline | 2019 | $449,900 | $225,000 | $749,988 | $749,995 | $18,648 | $2,193,531 |
Lawrence J. Hineline | 2018 | $424,400 | $203,700 | $749,986 | $732,430 | $17,292 | $2,127,808 |
Suresh Durgam, M.D. | 2020 | $448,575 | $274,400 | $599,984 | $599,997 | $7,385 | $1,930,341 |
Michael I. Halstead | 2020 | $512,000 | $320,000 | $1,119,985 | $479,990 | $17,931 | $2,449,906 |
Michael I. Halstead | 2019 | $497,100 | $323,100 | $749,988 | $749,995 | $17,270 | $2,337,453 |
Michael I. Halstead | 2018 | $469,000 | $225,100 | $749,986 | $732,430 | $16,680 | $2,193,196 |
Mark Neumann | 2020 | $518,900 | $324,312 | $1,119,985 | $479,990 | $130,085 | $2,573,272 |
Mark Neumann | 2019 | $503,800 | $277,100 | $799,991 | $799,997 | $133,449 | $2,514,337 |
Mark Neumann | 2018 | $106,090 | $245,500 | $749,995 | $749,990 | $25,124 | $1,876,699 |
Andrew Satlin, M.D. | 2020 | $480,634 | $0 | $1,119,985 | $479,990 | $20,585 | $2,101,194 |
Andrew Satlin, M.D. | 2019 | $515,000 | $360,500 | $874,997 | $874,996 | $19,332 | $2,644,825 |
Andrew Satlin, M.D. | 2018 | $500,000 | $300,000 | $0 | $0 | $11,792 | $811,792 |
No matching records found |
Source: https://www.sec.gov/Archives/edgar/data/1567514/000119312521140765/d80913ddef14a.htm
What are Intra-Cellular Therapies, Inc's Past Insider Trades?
Intra-Cellular Therapies, Inc's most recent insider trade came on September 19, 2023 by Sharon Mates who sold 100,000 units worth $5.39M . In the last 9 years, insiders at Intra-Cellular Therapies, Inc have sold an estimated value of $137.34M and bought an estimated value of $69.16M worth of shares. Insider trading is most common in January, with the busiest year in 2020. The most active traders at the company are Christopher Alafi, Director, Rory Riggs, Director, and Robert Nostrand Van, Director .
Intra-Cellular Therapies, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |